Oncolytics Biotech Inc. (ONCY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oncolytics Biotech Inc.

    NASDAQ: ONCY · Real-Time Price · USD
    1.29
    0.04 (3.20%)
    At close: Sep 26, 2025, 3:58 PM
    1.28
    -0.78%
    After-hours: Sep 26, 2025, 07:49 PM EDT

    Oncolytics Biotech Balance Sheet Statement

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 15.94M 34.91M 11.67M 41.26M
    Short-Term Investments
    		 n/a 3.38M 20.47M 1.36M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a 998K n/a
    Receivables
    		 68K 15K 521K n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 980K n/a n/a n/a
    Total Current Assets
    		 18.88M 38.17M 35.68M 44.9M
    Property-Plant & Equipment
    		 1.31M 647K 652K 976.29K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.31M 647K 1.65M 976.29K
    Total Assets
    		 20.19M 38.82M 37.33M 45.88M
    Account Payables
    		 1.09M 1.08M 2.25M 594K
    Deferred Revenue
    		 n/a n/a n/a -594K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 1.62M 532K 79K 407.84K
    Total Current Liabilities
    		 6.69M 4.24M 3.94M 2.69M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 6.73M n/a
    Total Long-Term Liabilities
    		 7.52M 7.02M 6.89M 7.09M
    Total Liabilities
    		 14.2M 11.26M 10.83M 9.78M
    Total Debt
    		 1.06M 423K 373K 654.75K
    Book Value
    		 5.98M 27.56M 26.5M 36.1M
    Book Value Per Share
    		 0.08 0.41 0.46 0.67
    Common Stock
    		 438.19M 430.91M 404.04M 391.35M
    Retained Earnings
    		 -477.71M -446M -418.25M -393.42M
    Comprehensive Income
    		 961K 544K 662K 387.74K
    Shareholders Equity
    		 5.98M 27.56M 26.5M 36.1M
    Total Investments
    		 n/a 3.38M 20.47M 1.36M

    Add to Watchlist